Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Comput Biol Chem ; 96: 107602, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1520797

ABSTRACT

Herein it is proposed that sufficient exposure to sunlight (UVB) modulates host gene expression, offering protection against severe consequences of COVID-19. This could be in addition to sunlight (UVB)-mediated protection by directly inactivating the virus and limiting the viral load. It is suggested that inhibition of CCR2, DPP9, HSPA1L, IFNAR2, OAS1, and TYK2 may, in part, explain UVB-mediated protection against severe consequences of COVID-19.


Subject(s)
COVID-19/prevention & control , SARS-CoV-2 , Sunlight , COVID-19/genetics , COVID-19/therapy , Computational Biology , Gene Expression/radiation effects , Gene Expression Profiling , Heliotherapy , Humans , Models, Biological , Severity of Illness Index , Ultraviolet Rays
2.
J Photochem Photobiol B ; 207: 111891, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-154800

ABSTRACT

The recent outbreak of COVID-19, which continues to ravage communities with high death tolls and untold psychosocial and catastrophic economic consequences, is a vivid reminder of nature's capacity to defy contemporary healthcare. The pandemic calls for rapid mobilization of every potential clinical tool, including phototherapy-one of the most effective treatments used to reduce the impact of the 1918 "Spanish influenza" pandemic. This paper cites several studies showing that phototherapy has immense potential to reduce the impact of coronavirus diseases, and offers suggested ways that the healthcare industry can integrate modern light technologies in the fight against COVID-19 and other infections. The evidence shows that violet/blue (400-470 nm) light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen's Nobel-winning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma. These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder. The ubiquity of inexpensive light emitting lasers and light emitting diodes (LEDs), makes it relatively easy to develop safe low-cost light-based devices with the potential to reduce infections, sanitize equipment, hospital facilities, emergency care vehicles, homes, and the general environment as pilot studies have shown.


Subject(s)
Coronavirus Infections/therapy , Phototherapy , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Heliotherapy , Humans , Infrared Rays , Light , Low-Level Light Therapy , Lung Diseases/epidemiology , Lung Diseases/therapy , Lung Diseases/virology , Pandemics , Phototherapy/methods , Pneumonia, Viral
SELECTION OF CITATIONS
SEARCH DETAIL